Carlyle Group Inc.
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 9, 2024), Carlyle Group Inc. reported 31 stock positions worth $1.1 billion. Its top holding was Quidelortho (QDEL) at 36.3% of the portfolio, followed by Zoominfo Technologies (GTM, 20.9%) and Soleno Therapeutics (SLNO, 15.8%). Compared with Q1 2024, it opened 1 new position, sold out of 2 and reduced 3. The biggest buy was a new position in Aon Class A (AON) and the biggest sale an exit from Vitru (VTRU).
- Most Recent 13F
- Q2 2026
- Location
- WASHINGTON, DC
- CIK
- 0001527166
- Portfolio Value
- $1.1B (Q2 2024)
- SEC Filing
- 0000898432-24-000692 ↗ filed Aug 9, 2024
Holdings Value
Holdings 31 stocks · $1.1B
| QDEL Quidelortho Corp. | 36.35% | 11,520,751 | $382.7M | Reduce -7.5% |
| GTM Zoominfo Technologies Inc. | 20.91% | 17,244,747 | $220.2M | Reduce -34.3% |
| SLNO Soleno Therapeutics Inc. | 15.80% | 4,071,562 | $166.4M | No change |
| GDS GDS Holdings Ltd. - ADR filed as GDS HLDGS LTD | 3.59% | 4,072,624 | $37.8M | No change |
| PHAT Phathom Pharmaceuticals Inc. | 3.40% | 3,496,808 | $35.8M | No change |
| VRNA Verona Pharma Ltd. | 3.37% | 2,457,500 | $35.5M | No change |
| GETY Getty Images Holdings Inc. | 2.85% | 9,212,799 | $30.0M | No change |
| HLVX Hillevax Inc. | 2.51% | 1,838,486 | $26.4M | No change |
| JSPR Jasper Therapeutics Inc. | 2.30% | 1,066,189 | $24.2M | No change |
| QTTB Q32 Bio Inc. | 1.82% | 1,102,741 | $19.2M | No change |
| SMHI Seacor Marine Holdings Inc. | 1.68% | 1,314,164 | $17.7M | No change |
| INVH Invitation Homes Inc. | 1.63% | 477,500 | $17.1M | No change |
| CUBE Cubesmart | 0.95% | 220,500 | $10.0M | No change |
| SPWR Sunpower Inc. filed as COMPLETE SOLARIA INC | 0.52% | 4,936,483 | $5.5M | No change |
| RENEO PHARMACEUTICALS INC | 0.39% | 2,698,957 | $4.2M | No change |
| EM Smart Share Global Ltd. - ADR | 0.39% | 4,810,209 | $4.1M | No change |
| DNUT Krispy Kreme Inc. | 0.35% | 340,748 | $3.7M | No change |
| ACET Adicet Bio Inc. | 0.34% | 2,948,718 | $3.6M | No change |
| SPRB Spruce Biosciences Inc. | 0.14% | 2,896,518 | $1.5M | No change |
| AON Aon PLC Class A | 0.14% | 4,973 | $1.5M | New |
| NABL N-Able Inc. | 0.14% | 93,732 | $1.4M | No change |
| AVGO Broadcom Inc. | 0.12% | 755 | $1.2M | No change |
| SWI Solarwinds Corp. | 0.11% | 93,735 | $1.1M | No change |
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 0.07% | 55,417 | $714K | Reduce -23.4% |
| DASH DoorDash Inc. Class A | 0.04% | 4,156 | $452K | No change |
| NCNA Nucana PLC | 0.03% | 133,333 | $340K | No change |
| SYRE Spyre Therapeutics Inc. | 0.02% | 9,620 | $227K | No change |
| META DATA LIMITED | 0.01% | 314,400 | $133K | No change |
| XCUR Exicure Inc. | 0.01% | 281,636 | $89K | No change |
| EFTR Effector Therapeutics Inc. | 0.01% | 192,884 | $56K | No change |
| MTEMQ Molecular Templates Inc. | 0.00% | 13,333 | $15K | No change |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
| AON Aon PLC Class A | New | 0.14% | +0.14 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $10.0B | MDLN, SARO, PHAT, INVH, PONY |
| Q1 2026 | 20 | $10.6B | MDLN, SARO, PHAT, PONY, INVH |
| Q4 2025 | 20 | $13.6B | MDLN, SARO, PHAT, PONY, INVH |
| Q3 2025 | 17 | $4.3B | SARO, PONY, PHAT, SPRB, INVH |
| Q2 2025 | 20 | $5.0B | SARO, SLNO, PHAT, PONY, INVH |
| Q1 2025 | 23 | $3.8B | SARO, SLNO, WRD, PHAT, PONY |
| Q4 2024 | 27 | $4.1B | SARO, SLNO, WRD, PONY, PHAT |
| Q3 2024 | 26 | $954.2M | QDEL, SLNO, GTM, PHAT, QTTB |
| Q2 2024 | 31 | $1.1B | QDEL, GTM, SLNO, GDS, PHAT |
| Q1 2024 | 32 | $1.6B | QDEL, GTM, SLNO, VTRU, VRNA |